Related Experiment Video
Updated: May 24, 2025
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
An open letter to the NIH cardiovascular study section reviewers
1Molecular Medicine (Genetics) and Internal Medicine (Cardiology), Institute of Molecular Medicine, and the Department of Medicine, The University of Texas Health Science Center, Houston, TX, USA. Ali.J.Marian@uth.tmc.edu.
Insights
Reviewers at the National Institutes of Health (NIH) guide scientific discovery. This paper addresses concerns about National Heart, Lung, and Blood Institute (NHLBI) review quality and suggests improvements for grant application assessments.
Area of Science:
- Biomedical research funding and review processes.
- Grant application evaluation in scientific fields.
Background:
- National Institutes of Health (NIH) study sections are crucial for funding scientific research.
- Reviewers significantly influence the direction of scientific discoveries and patient care.
- Concerns have been raised regarding the quality of reviews from the National Heart, Lung, and Blood Institute (NHLBI) study section.
Purpose of the Study:
- To discuss concerns about NHLBI study section review quality.
- To identify specific deficiencies in the current review process.
- To provide actionable suggestions for improving grant application reviews.
Main Methods:
- Analysis of investigator concerns regarding NHLBI reviews.
- Identification of common deficiencies in scientific grant reviews.
- Formulation of recommendations for study section reviewers.
Main Results:
- Specific quality concerns with NHLBI grant reviews have been articulated.
- Deficiencies in the review process have been identified.
- Suggestions for enhancing reviewer performance are proposed.
Conclusions:
- Improving the quality of grant reviews is essential for scientific progress.
- Addressing reviewer concerns can enhance the integrity of the NIH funding process.
- Implementing suggested improvements can lead to more equitable and effective grant evaluations.
Abstract:
The reviewers who serve at the National Institute of Health (NIH) study sections are in the unique position of identifying the most scientifically meritorious grant applications for consideration for funding. Consequently, the reviewers guide the direction of scientific discoveries in the US, which ultimately translate to patient care. Recently many investigators have expressed concerns about the quality of the reviews that they received from the National Heart, Lung, and Blood Institute (NHLBI) study section reviewers. I discuss some of these concerns, identify some of the deficiencies, and make suggestions to the reviewers on how to improve their review of the grant applications.
